Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 501–600 of 1,006
microRNAs as early biomarkers of Alzheimer’s disease: a synaptic perspective
Siedlecki-Wullich, D., Miñano-Molina, A. J., & Rodríguez-Álvarez, J. (2021) · Cells · doi:10.3390/cells10010113 · Cited by 76
“For instance, the cascade triggered by oAβ affect the regulation of downstream kinases and phosphatases that increase NMDAR and AMPAR internalization [28,37,40], creating an imbalance between LTP and LTD.”
Backgroundβ2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function
Gao, Y., Hong, Y., Huang, L., Zheng, S., Zhang, H., Wang, S., Yao, Y., Zhao, Y., Zhu, L., Xu, Q., et al. (2023) · Cell · doi:10.1016/j.cell.2023.01.021 · Cited by 75
Prasansuklab, A., & Tencomnao, T. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/413808 · Cited by 75
The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer's Disease
Small, D. H., Gasperini, R., Vincent, A. J., Hung, A. C., & Foa, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0951 · Cited by 75
Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease
Spires-Jones, T. L., Mielke, M. L., Rozkalne, A., Meyer-Luehmann, M., de Calignon, A., Bacskai, B. J., Schenk, D., & Hyman, B. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.011 · Cited by 74
“Recent data support the idea that synaptotoxicity is mediated by soluble, oligomeric forms of Aβ [5,13,34], which may provide such a link.”
Cumiskey, D., Butler, M. P., Moynagh, P. N., & O'Connor, J. J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.019 · Cited by 81
Hu, R., Wei, P., Jin, L., Zheng, T., Chen, W.-Y., Liu, X.-Y., Shi, X.-D., Hao, J.-R., Sun, N., & Gao, C. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.140 · Cited by 75
“Soluble amyloid-beta (Aβ) oligomers, also known as Aβ-derived diffusible ligands (ADDLs) play an important role in AD.”
InfluentialCaetano, F. A., Beraldo, F. H., Hajj, G. N. M., Guimaraes, A. L., Jürgensen, S., Wasilewska-Sampaio, A. P., Hirata, P. H. F., Souza, I., Machado, C. F., Wong, D. Y.-L., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07225.x · Cited by 74
Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., Toldi, J., & Vécsei, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132621 · Cited by 83
“synaptic AMPARs and NMDARs [55, 56] and non-”
Kohli, B. M., Pflieger, D., Mueller, L. N., Carbonetti, G., Aebersold, R., Nitsch, R. M., & Konietzko, U. (2012) · Journal of Proteome Research · doi:10.1021/pr300123g · Cited by 74
NMDA-Receptor Activation but Not Ion Flux Is Required for Amyloid-Beta Induced Synaptic Depression
Tamburri, A., Dudilot, A., Licea, S., Bourgeois, C., & Boehm, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065350 · Cited by 74
“Through its effect on NMDA-receptor and AMPA-receptor dephosphorylation and subsequent receptor internalization, STEP was described as a more general modulator of synaptic plasticity [28].”
InfluentialHicklin, T. R., Wu, P. H., Radcliffe, R. A., Freund, R. K., Goebel-Goody, S. M., Correa, P. R., Proctor, W. R., Lombroso, P. J., & Browning, M. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017856108 · Cited by 81
“Activation of STEP has been shown to dephosphorylate this site (31), and we previously showed that ethanol treatment also leads todephosphorylationofTyr(1472) in rat hippocampal slices (13, 20).”
Self-citationCalcium signalling: A common target in neurological disorders and neurogenesis
Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.12.002 · Cited by 79
The role of amyloids in Alzheimer's and Parkinson's diseases
Salahuddin, P., Fatima, M. T., Uversky, V. N., Khan, R. H., Islam, Z., & Furkan, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.197 · Cited by 81
Cheng, F., Li, X., Li, Y., Wang, C., Wang, T., Liu, G., Baskys, A., Uéda, K., Chan, P., & Yu, S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07460.x · Cited by 73
Gardoni, F., Marcello, E. E., & Luca, M. D. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.068 · Cited by 82
“At a postsynaptic level, application of A has been hown to promote endocytosis of NMDA receptors in corical neurons (Snyder et al., 2005).”
BackgroundFu, Y., Zhao, J., Atagi, Y., Nielsen, H. M., Liu, C.-C., Zheng, H., Shinohara, M., Kanekiyo, T., & Bu, G. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0099-y · Cited by 69
“signaling receptors including N-methyl D-aspartate (NMDA) receptors [39] and metabotropic glutamate receptors (mGluR5) [40], leading to synapse deterioration and impairment of learning and memory.”
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73
“Both Aβ1-40 and Aβ1-42 have been shown to interact with several receptors including the N-Methyl-D-Aspartate (NMDA), α-Amino-3-hydroxy-5-Methyl-4-isoxazole Propionic acid (AMPA), nicotinic Acetylcholine (nACh), and muscarinic Acetylcholine (mACh) receptors (Tozaki et al., 2002; Snyder et al., 2005; Liskowsky and Schli…”
BackgroundOlajide, O. J., Suvanto, M. E., & Chapman, C. A. (2021) · Biology Open · doi:10.1242/bio.056796 · Cited by 79
“In addition, Aβ-mediated reduction in glutamate receptors and rapid degeneration of synaptic elements in hippocampal neurons were attributed to activation of apoptotic factors (Snyder et al., 2005; Liu et al., 2010).”
BackgroundPérez‐González, R., Alvira-Botero, X., Avendaño, O. F. R., Antequera, D., Garzón, M., Martín-Moreno, A. M., Brera, B., CEBALLOS, M. L. D., & Carro, E. (2014) · Gene Therapy · doi:10.1038/gt.2013.85 · Cited by 79
Wang, Y., & Mattson, M. P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.007 · Cited by 72
“Interestingly, previous studies have suggested that exposure of neurons to Ab reduces NMDA currents (Snyder et al., 2005), as does expression of mutant PS1 (Wang et al.”
BackgroundFolwell, J., Cowan, C. M., Ubhi, K. K., Shiabh, H., Newman, T. A., Shepherd, D., & Mudher, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.014 · Cited by 83
Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors
Abbott, J. J., Howlett, D. R., Francis, P. T., & Williams, R. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.003 · Cited by 255
Nakajima, A., Yamakuni, T., Matsuzaki, K., Nakata, N., Onozuka, H., Yokosuka, A., Sashida, Y., Mimaki, Y., & Ohizumi, Y. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117010 · Cited by 73
“Considering the ability of nobiletin to trigger an increase in CREB phosphorylation and cAMP response element-dependent transcription via activation of a cAMP/PKA/ERK signaling pathway in cultured rat hippocampal neurons (K. Matsuzaki, T. Yamakuni, S. Moriguchi, K. Fukunaga, A. Yokosuka, Y. Sashida, Y. Mimaki, and Y.…”
InfluentialSaavedra, A., Giralt, A., Rué, L., Xifró, X., Xu, J., Ortega, Z., Lucas, J. J., Lombroso, P. J., Alberch, J., & Pérez‐Navarro, E. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3446-10.2011 · Cited by 75
“Once activated, STEP dephosphorylates the glutamate receptor subunits NR2B (Pelkey et al., 2002; Snyder et al., 2005; Braithwaite et al., 2006) and GluR2 (Zhang et al., 2008), leading to their endocytosis, and the kinases ERK1/2 (extracellular signal-regulated kinase 1/2), p38, and Fyn, thereby controlling the duratio…”
Self-citationHamilton, A., Zamponi, G. W., & Ferguson, S. S. G. (2015) · Molecular Brain · doi:10.1186/s13041-015-0107-0 · Cited by 78
“In cultured neurons Aβ42 oligomers appear to initiate spontaneous NMDAR currents and NMDAR internalization [97,98] and a number of studies have shown that the molecular mechanisms underlying Aβ42-dependent alterations in NMDAR activity and trafficking are complex [97,99].”
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
Yan, R., Fan, Q., Zhou, J., & Vassar, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.025 · Cited by 71
A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade
Granzotto, A., Canzoniero, L. M. T., & Sensi, S. L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.600089 · Cited by 67
“Of note, Aβ can also promote the endocytosis of NMDA-type glutamate receptors, a mechanism that, later on, may contribute to the synaptic failure observed in AD (Snyder et al., 2005).”
BackgroundAn Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70
Schumann, J., Alexandrovich, G. A., Biegon, A. R., & Yaka, R. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0521 · Cited by 78
“-induced internalization of the NMDAR in dissociated cortical neurons (Snyder et al., 2005).”
Qiang, M., Denny, A. D., & Ticku, M. K. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033043 · Cited by 70
“Neurons were then lysed, and the remainder of the assay was the same as that in surface expression (Snyder et al., 2005).”
InfluentialMetal complexes as artificial proteases: toward catalytic drugs
Suh, J., & Chei, W. S. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.028 · Cited by 81
MAPK, β-amyloid and synaptic dysfunction: the role of RAGE
Origlia, N., Arancio, O., Domenici, L., & Yan, S. S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.107 · Cited by 70
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 75
“binding of AβOs to NMDAR subunits has been reported in many studies [45, 47, 79].”
Yang, H., Yang, X. Z., Cao, J., Li, S., Liu, Y.-N., Suo, Z., Cui, H., Guo, Z., & Hu, X. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07088.x · Cited by 70
Poddar, R., Deb, I., Mukherjee, S., & Paul, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07035.x · Cited by 77
Self-citationSakurai, M., Sekiguchi, M., Zushida, K., Yamada, K., Nagamine, S., Kabuta, T., & Wada, K. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06047.x · Cited by 75
“, 2003) and in AD model mice (Chapman et al., 1999; Freir et al., 2001; Snyder et al., 2005; Shemer et al., 2006), which supports the hypothesis that synapses may be an initial target in AD (Small et al.”
A role for the neurexin–neuroligin complex in Alzheimer's disease
Sindi, I. A., Tannenberg, R. K., & Dodd, P. R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.032 · Cited by 68
Striatal‐enriched protein tyrosine phosphatase (STEP) knockout mice have enhanced hippocampal memory
Venkitaramani, D. V., Moura, P. J., Picciotto, M. R., & Lombroso, P. J. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07687.x · Cited by 68
“We have also shown that endocytosis of NMDARs by amyloid-b (Kurup et al., 2010a,b) and internalization of AMPARs in response to (RS)-3,5-dihydroxyphenylglycine DHPG (Zhang et al., 2008) are both reduced in STEP KO mice and this is reversed by the restoration of active STEP protein to neuronal cultures.”
InfluentialSelf-citationCousins, S. L., Hoey, S. E. A., Anne Stephenson, F., & Perkinton, M. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06424.x · Cited by 68
Jakaria, M., Park, S., Haque, M. E., Karthivashan, G., Kim, I., Ganesan, P., & Choi, D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00307 · Cited by 79
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease
Uddin, M. S., Kabir, M. T., Tewari, D., Mamun, A. A., Mathew, B., Aleya, L., Barreto, G. E., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116974 · Cited by 76
Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
Vyas, Y., Montgomery, J. M., & Cheyne, J. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00266 · Cited by 66
Fyn, a Potential Target for Alzheimer's Disease
Yang, K., Belrose, J., Trepanier, C. H., Lei, G., Jackson, M. F., & MacDonald, J. F. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110353 · Cited by 67
“Furthermore, NMDAR expression was reduced following A exposure in vitro, in both transgenic AD mouse models and sporadic AD [53–55].”
EphBs: an integral link between synaptic function and synaptopathies
Sheffler-Collins, S. I., & Dalva, M. B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.003 · Cited by 67
N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein
Ando, K., Uemura, K., Kuzuya, A., Maesako, M., Asada-Utsugi, M., Kubota, M., Aoyagi, N., Yoshioka, K., Okawa, K., Inoue, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158477 · Cited by 66
Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
Netzer, W. J., Powell, C., Nong, Y., Blundell, J., Wong, L., Duff, K., Flajolet, M., & Greengard, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010943 · Cited by 67
“observed in Ts65Dn mice treated with the c-secretase inhibitor, DAPT, resulted from lowered Ab levels [26,27,28].”
Self-citationSynaptotoxicity in Alzheimer's Disease: The Wnt Signaling Pathway as a Molecular Target
Inestrosa, N. C., Varela‐Nallar, L., Grabowski, C. P., & Colombres, M. (2007) · IUBMB Life · doi:10.1080/15216540701242490 · Cited by 67
Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67
“In human patients high plasma concentrations of Aβ40 are associated with an increased risk of dementia [54] and along with Aβ42, Aβ40 is known to impair hippocampal LTP in rats [55-57] and to alter glutamate receptor composition and trafficking and synaptic function [58,59].”
Aβ-Induced Synaptic Alterations Require the E3 Ubiquitin Ligase Nedd4-1
Rodrigues, E. M., Scudder, S. L., Goo, M. S., & Patrick, G. N. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2964-15.2016 · Cited by 66
“Several studies reveal that elevated levels of A lead to the loss of glutamate receptors (Snyder et al., 2005; Hsieh et al., 2006).”
Estructura y función de las subunidades del receptor a glutamato tipo NMDA
Flores-Soto, M. E., Chaparro-Huerta, V., Escoto-Delgadillo, M., Vázquez-Valls, E., González-Castañeda, R. E., & Beas‐Zárate, C. (2012) · Neurología · doi:10.1016/j.nrl.2011.10.014 · Cited by 83
CSF Biomarkers: Pinpointing Alzheimer Pathogenesis
Mattsson, N., Blennow, K., & Zetterberg, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04944.x · Cited by 66
Dhawan, J., Benveniste, H., Nawrocky, M. M., Smith, S. D. B., & Biegon, A. R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.073 · Cited by 65
“NMDAR internalization in response to amyloid beta release, which was reported in MCAO rats (Li et al., 2010; Snyder et al., 2005).”
Yamamoto, K., Ueta, Y., Wang, L., Yamamoto, R., Inoue, N., Inokuchi, K., Aiba, A., Yonekura, H., & Kato, N. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6752-10.2011 · Cited by 66
Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N., Mirfakhar, F. S., Castanheira, J., & Guimas Almeida, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 65
“…(Wang et al., 2017; Willén et al., 2017), increasing calcium influx, which triggers AMPA and NMDA receptor phosphorylation leading to their removal from synapses by endocytosis (Snyder et al., 2005; Liu et al., 2010; Miñano-Molina et al., 2011; Sinnen et al., 2016; Baglietto-Vargas et al., 2018).”
BackgroundSelf-citationRole of Calcium in the Pathogenesis of Alzheimer’s Disease and Transgenic Models
Green, K. N., Smith, I. F., & LaFerla, F. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_19 · Cited by 79
Seredenina, T. S., Gökçe, Ö., & Luthi‐Carter, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022231 · Cited by 65
“Reciprocally, STEP activation has been shown to negatively regulate NMDA receptor stimulation via dephosphorylating and promoting the endocytosis of the NMDA receptor subunit NR2B [27]. b) Ras homolog enriched in striatum (Rhes/RASD2): RASD2 is a member of the large ras superfamily of proteins [28,29].”
Shimazawa, M., Inokuchi, Y., Okuno, T., Nakajima, Y., Sakaguchi, G., Kato, A., Oku, H., Sugiyama, T., Kudo, T., Ikeda, T., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05606.x · Cited by 65
Qiu, S., Li, X., & Zhuo, M. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.06.003 · Cited by 76
Dysregulation of dynorphins in Alzheimer disease
Yakovleva, T., Marinova, Z., Kuzmin, A., Seidah, N. G., Haroutunian, V., Terenius, L. Y., & Bakalkin, G. Y. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.07.002 · Cited by 72
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 76
Neuronal nicotinic acetylcholine receptor–cholesterol crosstalk in Alzheimer's disease
Barrantes, F. J., Borroni, V., & Vallés, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.11.036 · Cited by 67
“Ab also affects the endocytosis of the NMDA receptor; upon a7 AChR stimulation, NMDA receptors are internalized in an Ab-dependent manner, leading to a weakening of synaptic strength [21].”
Baglietto‐Vargas, D., Prieto, G. A., Limon, A., Forner, S., Rodriguez‐Ortiz, C. J., Ikemura, K., Ager, R. R., Medeiros, R., Trujillo‐Estrada, L., Martini, A. C., et al. (2018) · Aging Cell · doi:10.1111/acel.12791 · Cited by 65
“These previous findings support our study demonstrating significant decreases in the phosphorylation state of multiple NMDARs subunits and cortactin.”
BackgroundInfluentialAnti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies
Nakajima, A., Ohizumi, Y., & Yamada, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.2.75 · Cited by 64
Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A
Wang, H.-Y., Bakshi, K., Frankfurt, M., Stucky, A., Goberdhan, M., Shah, S. M., & Burns, L. H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0354-12.2012 · Cited by 63
“Importantly, PTI-125 preserves or restores the signaling functions of 7nAChR, NMDAR, which is regulated by 7nAChR (Snyder et al., 2005; Wang et al., 2009), and IR.”
Hu, J.-L., Liu, G., Li, Y.-C., Gao, W.-J., & Huang, Y.-Q. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-20 · Cited by 64
“It is increasingly appreciated that NMDA receptor trafficking dysregulation may contribute to neuropsychiatric disorders such as drug addiction [43], Alzheimer's disease [44], and schizophrenia [45].”
Glutamatergic plasticity and alcohol dependence-induced alterations in reward, affect and cognition
Burnett, E. J., Chandler, L. J., & Trantham‐Davidson, H. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.012 · Cited by 72
“Given that GluN2B dephosphorylation is associated with receptor endocytosis (Snyder et al., 2005), these data may be indicative of a homeostatic adaptation that AC C EP TE D M AN U SC R IP T presumably is a mechanism by which the brain prevents prolonged overexpression of GluN2Bcontaining receptors.”
Structure and function of NMDA-type glutamate receptor subunits
Flores-Soto, M. E., Chaparro-Huerta, V., Escoto-Delgadillo, M., Vázquez-Valls, E., González-Castañeda, R. E., & Beas‐Zárate, C. (2012) · Neurología (English Edition) · doi:10.1016/j.nrleng.2011.10.003 · Cited by 90
“These data indicate the presence of a new mechanism by which -amyloid may contribute to AD neuropathology: originating synaptic dysfunction by inhibiting the functional location of NMDA-type Glu receptors on the synaptic level.(64)”
Alcohol‐dependent molecular adaptations of the NMDA receptor system
Morisot, N., & Ron, D. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12363 · Cited by 68
“Finally, STEP was reported to dephosphorylate GluN2B leading to channel internalization (Snyder et al. 2005).”
Cellular calcium signaling in the aging brain
Remya, C., Kumar, M., Kesavan, L., Jacob, R. S., Gunasekaran, S., Lakshmi, S., Sadasivan, C., & Omkumar, R. V. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.11.008 · Cited by 67
“Increased phosphatase activity is favored during aging (Norris et al., 1998) which can lead to internalization of NMDA receptors thereby resulting in hypofunction (Snyder et al., 2005).”
BackgroundYang, X., Gong, R., Qin, L., Bao, Y., Fu, Y., Gao, S., Yang, H., Ni, J. D., Yuan, T., & Lü, W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111217 · Cited by 73
Synapto‐depressive effects of amyloid beta require PICK 1
Alfonso, S., Kessels, H. W., Banos, C. C., Chan, T. R., Lin, E. T., Kumaravel, G., Scannevin, R. H., Rhodes, K. J., Huganir, R., Guckian, K. M., et al. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12499 · Cited by 61
“, 2010), a physiological process that may be hijacked by Ab to produce synaptic depression (Snyder et al., 2005; Hsieh et al., 2006).”
InfluentialSTEP61is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s disease
Kurup, P. K., Xu, J., Videira, R. A., Ononenyi, C., Baltazar, G., Lombroso, P. J., & Nairn, A. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417423112 · Cited by 62
“Other STEP substrates include the GluN2B subunit of the NMDA receptor and the GluA2 subunit of the AMPA receptor, and STEP dephosphorylation results in internalization of both GluN1/GluN2B and GluA1/GluA2 receptors (18, 58).”
Self-citationContestabile, A., Ciani, E., & Contestabile, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9497-4 · Cited by 74
Auffret, A., Gautheron, V., Repici, M., Kraftsik, R., Mount, H. T. J., Mariani, J., & Rovira, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1856-09.2009 · Cited by 62
“A growing body of evidence suggests that the study of excitatory synaptic transmission (Kamenetz et al., 2003; Snyder et al., 2005; Chang et al., 2006) is essential to understand early events that contribute to the development of AD before neurodegeneration occurs.”
Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s Disease
Hottman, D. A., & Li, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8627-z · Cited by 61
“One of the mechanisms by which Aβ impairs synaptic function is by promoting endocytosis of NMDA receptors, thereby reducing the presence of NMDA receptors at the cell surface [58].”
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
Yu, C., Nwabuisi-Heath, E., Laxton, K., & LaDu, M. J. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-19 · Cited by 62
“Extracellular oAb has been proposed to bind the cell surface, leading to functional disruption of NMDAR [26,27] and AMPAR [28,29], and activation of caspases [30].”
SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus
Marcello, E. E., Epis, R., Saraceno, C., Gardoni, F., Borroni, B., Cattabeni, F., Padovani, A., & Luca, M. D. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.015 · Cited by 69
“…a direct action of A peptides and oligomers on the postsynaptic membrane of excitatory synapse , describing in in vitro systems an interference of A on glutamate receptor trafficking and function and on spine formation (Lacor et al., 2007; Shankar et al., 2007, 2008; Snyder et al., 2005).”
Bharadwaj, P., Solomon, T., Malajczuk, C. J., Mancera, R. L., Howard, M. J., Arrigan, D. W. M., Newsholme, P., & Martins, R. N. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.015 · Cited by 66
The Role of D-Amino Acids in Alzheimer’s Disease
Piubelli, L., Murtas, G., Rabattoni, V., & Pollegioni, L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201217 · Cited by 69
The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases
de Pins, B., Mendes, T., Giralt, A., & Girault, J. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.749001 · Cited by 69
FIB/SEM Technology and Alzheimer's Disease: Three-Dimensional Analysis of Human Cortical Synapses
Blazquez-Llorca, L., Merchán-Pérez, Á., Rodríguez, J.-R., Gascón, J., & DeFelipe, J. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-122038 · Cited by 61
Marcello, E. E., Epis, R., & Luca, M. D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.083 · Cited by 67
“PP2B dephosphorylates and activates striatal-enriched tyrosine phosphatase (STEP), which dephosphorylates the NMDA receptor subunit 2B (NR2B) at Tyr(1472) and promotes internalization of NR2B containing NMDA receptors (Snyder et al., 2005).”
Rui, Y., Gu, J., Yu, K., Hartzell, H. C., & Zheng, J. Q. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-10 · Cited by 61
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. excitatory synaptic transmission are alpha-ami…”
InfluentialRoss, J. A., Gliebus, G., & Van Bockstaele, E. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.004 · Cited by 61
Creatine as a Neuroprotector: an Actor that Can Play Many Parts
Marques, E. P., & Wyse, Â. T. D. S. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00053-7 · Cited by 67
Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway
Marshall, K. E., Vadukul, D. M., Staras, K., & Serpell, L. C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03464-4 · Cited by 61
Dynamin-dependent NMDAR endocytosis during LTD and its dependence on synaptic state
Montgomery, J. M., Selcher, J. C., Hanson, J. E., & Madison, D. V. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-48 · Cited by 61
“These techniques may not be sensitive enough to detect activity-dependent changes in NMDAR expression measured by alternative methods [18,20-23].”
Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice
Tzeng, T.-C., Hasegawa, Y., Iguchi, R., Cheung, A., Caffrey, D. R., Thatcher, E. J., Mao, W., Germain, G., Tamburro, N. D., Okabe, S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801802115 · Cited by 67
The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease
Buawangpong, N., Pinyopornpanish, K., Siri‐Angkul, N., Chattipakorn, N., & Chattipakorn, S. C. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30646 · Cited by 60
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
Koukouli, F., & Maskos, U. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.018 · Cited by 69
Sadleir, K. R., & Vassar, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333914 · Cited by 52
Profiling of mouse synaptosome proteome and phosphoproteome by IEF
Filiou, M. D., Bisle, B., Reckow, S., Teplytska, L., Maccarrone, G., & Turck, C. W. (2010) · ELECTROPHORESIS · doi:10.1002/elps.200900647 · Cited by 60
Shi, X.-D., Sun, K., Hu, R., Liu, X.-Y., Hu, Q.-M., Sun, X.-Y., Yao, B., Sun, N., Hao, J.-R., Wei, P., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1327-16.2016 · Cited by 60
Ghrelin in Alzheimer’s disease: Pathologic roles and therapeutic implications
Jeon, S. G., Hong, S. B., Nam, Y., Tae, J., Yoo, A., Song, E. J., Kim, K. I., Lee, D., Park, J., Lee, S. M., et al. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100945 · Cited by 58
Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease
Padmanabhan, P., Kneynsberg, A., & Götz, J. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00531-y · Cited by 59
Rao, J. S., Ertley, R. N., Rapoport, S. I., Bazinet, R. P., & Lee, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04648.x · Cited by 59
RetractedAnimal models of neurodegenerative diseases
Ribeiro, F. M., Camargos, E. R. D. S., de Souza, L. C., & Teixeira, A. L. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1157 · Cited by 74
Wang, H., Megill, A., He, K., Kirkwood, A., & Lee, H.-K. (2012) · Neural Plasticity · doi:10.1155/2012/272374 · Cited by 59
“A recent study showed that application of both synthetic Aβ42 peptides and naturally secreted Aβ, from APPSwe (K670N/M671L mutation) Tg mice, promotes endocytosis of surface NMDARs and hence depresses NMDAR current in wildtype cultured cortical neurons [97].”
BackgroundLithner, C. U., Svedberg, M. M., Yu, W., Hedberg, M. M., & Nordberg, A. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098566 · Cited by 63
“Neuronal cell cultures from APPswe transgenic mice showed a reduction in surface-expressed NMDA receptors, whereas no change was observed in total receptor number (Snyder et al., 2005).”
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.